Paper42576759
[Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia].
Shang Q and 4 others. Hua Xi Kou Qiang Yi Xue Za Zhi, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. [Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia]. Papers, record 42576759. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42576759
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- [Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia].
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Thalidomide | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Leukoplakia, Oral | Major topic |
| Humans | |
| Molecular Docking Simulation | |
| Signal Transduction | |
| Protein Interaction Maps | |
| DNA (Cytosine-5-)-Methyltransferase 1 | |
| Poly (ADP-Ribose) Polymerase-1 | |
| Network Pharmacology | |
| Proto-Oncogene Mas |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35152645 | [Guideline for the diagnosis and treatment of oral lichen planus (revision)]. | Zhonghua Kou Qiang Yi Xue Za Zhi | 2022 | https://conductscience.org/library/papers/35152645 | PubMed |
| 2 | 34982498 | Oral leukoplakia: A clinicopathological study and malignant transformation. | Oral Dis | 2023 | https://conductscience.org/library/papers/34982498 | PubMed |
| 3 | 33993200 | Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours. | Oncogenesis | 2021 | https://conductscience.org/library/papers/33993200 | PubMed |
| 4 | 36430388 | MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430388 | PubMed |
| 5 | 38503157 | c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38503157 | PubMed |
| 6 | 23318436 | Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy. | Oncogene | 2013 | https://conductscience.org/library/papers/23318436 | PubMed |
| 7 | 39290142 | Recurrence in Oral Leukoplakia: A Systematic Review and Meta-analysis. | J Dent Res | 2024 | https://conductscience.org/library/papers/39290142 | PubMed |
| 8 | 28676700 | The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. | Nat Rev Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28676700 | PubMed |
| 9 | 33451333 | Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. | Mol Cancer | 2021 | https://conductscience.org/library/papers/33451333 | PubMed |
| 10 | 35236826 | Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35236826 | PubMed |
| 11 | 39239507 | Single-cell RNA sequencing highlights the immunosuppression of IDO1+ macrophages in the malignant transformation of oral leukoplakia. | Theranostics | 2024 | https://conductscience.org/library/papers/39239507 | PubMed |
| 12 | 37752089 | Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside. | J Zhejiang Univ Sci B | 2023 | https://conductscience.org/library/papers/37752089 | PubMed |
| 13 | 41123100 | Decoding Spatiotemporal Microenvironmental Changes in Oral Carcinogenesis. | J Dent Res | 2026 | https://conductscience.org/library/papers/41123100 | PubMed |
| 14 | 33217066 | The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis. | J Oral Pathol Med | 2021 | https://conductscience.org/library/papers/33217066 | PubMed |
| 15 | 29991692 | Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis. | Sci Rep | 2018 | https://conductscience.org/library/papers/29991692 | PubMed |
| 16 | 34165402 | Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs. | Curr Med Chem | 2022 | https://conductscience.org/library/papers/34165402 | PubMed |
| 17 | 39314164 | Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis. | Oral Dis | 2025 | https://conductscience.org/library/papers/39314164 | PubMed |
| 18 | 35081970 | Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35081970 | PubMed |
| 19 | 22704061 | Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. | Oral Oncol | 2012 | https://conductscience.org/library/papers/22704061 | PubMed |
| 20 | 25156040 | Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25156040 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| AURKA | 6790 | PubTator's text mining | https://conductscience.org/library/genes/6790 | NCBI Gene |
| DNMT1 | 1786 | PubTator's text mining | https://conductscience.org/library/genes/1786 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
| PTK2B | 2185 | PubTator's text mining | https://conductscience.org/library/genes/2185 | NCBI Gene |
| RET | 5979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
| SLTM | 79811 | PubTator's text mining | https://conductscience.org/library/genes/79811 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42576759
GET https://conductscience.org/api/papers/v1/42576759/references?page=2